May 6, 2026 · by SmartPeptide Editorial
GLP-1 peptide research
Semaglutide and tirzepatide: the strongest peptide evidence base today.
Educational only — not medical advice. SmartPeptide does not prescribe, diagnose, or treat. Always consult a licensed healthcare provider before using any peptide, supplement, medication, or protocol.
# GLP-1 peptide research
This article is educational only. SmartPeptide does not provide medical advice.
Semaglutide and tirzepatide: the strongest peptide evidence base today.
## Background
This is placeholder content for the MVP. Replace it from the admin back office.
## What the research says
Research quality varies dramatically across peptides. Some have decades of Phase 3 trial data; others have only animal studies.
## Questions to ask a clinician
- What does the human evidence actually look like?
- What are the known and unknown risks?
- How will we measure benefit and harm?
## Disclaimer
Nothing on SmartPeptide is medical advice. Always consult a licensed healthcare provider.